These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8556973)

  • 21. Interventions to reduce HIV transmission related to injecting drug use in prison.
    Jürgens R; Ball A; Verster A
    Lancet Infect Dis; 2009 Jan; 9(1):57-66. PubMed ID: 19095196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Syringe sharing in prison.
    Pickering H; Stimson GV
    Lancet; 1993 Sep; 342(8871):621-2. PubMed ID: 8102754
    [No Abstract]   [Full Text] [Related]  

  • 23. HIV in prison: what are the risks and what can be done?
    Hellard ME; Aitken CK
    Sex Health; 2004; 1(2):107-13. PubMed ID: 16334992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tattooing in prisons--not such a pretty picture.
    Hellard ME; Aitken CK; Hocking JS
    Am J Infect Control; 2007 Sep; 35(7):477-80. PubMed ID: 17765561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV risk behaviour correlates among injecting drug users in Greek prisons.
    Koulierakis G; Gnardellis C; Agrafiotis D; Power KG
    Addiction; 2000 Aug; 95(8):1207-16. PubMed ID: 11092068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-site samples of injecting drug users in Edinburgh: prevalence and correlates of risky injecting practices.
    Peters A; Davies T; Richardson A
    Addiction; 1998 Feb; 93(2):253-67. PubMed ID: 9624726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
    Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
    N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harm reduction measures and injecting inside prison versus mandatory drugs testing: results of a cross sectional anonymous questionnaire survey. The European Commission Network on HIV Infection and Hepatitis in Prison.
    Bird AG; Gore SM; Hutchinson SJ; Lewis SC; Cameron S; Burns S
    BMJ; 1997 Jul; 315(7099):21-4. PubMed ID: 9233321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
    Larney S
    Addiction; 2010 Feb; 105(2):216-23. PubMed ID: 20078480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie.
    Bird AG; Gore SM; Cameron S; Ross AJ; Goldberg DJ
    AIDS; 1995 Jul; 9(7):801-8. PubMed ID: 7546427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk dimensions of HIV-tested substance users.
    Ottomanelli G
    Int J Addict; 1993 Dec; 28(14):1487-95. PubMed ID: 8307661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Examining HIV, drug use and risk behaviours: A case study in the custodial settings of Thailand and Indonesia.
    Thomson N; Reid G; Dolan K
    Int J Prison Health; 2009; 5(4):180-91. PubMed ID: 25757519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sharing injecting equipment and sexual behavior in ambulatory intravenous drug users: a national survey (Spain).
    Bravo MJ; Delgado-Rodríguez M; de la Fuente L; Lardelli P; Barrio G; López R
    Int J Addict; 1994 Dec; 29(14):1893-907. PubMed ID: 7890447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.
    Weild AR; Gill ON; Bennett D; Livingstone SJ; Parry JV; Curran L
    Commun Dis Public Health; 2000 Jun; 3(2):121-6. PubMed ID: 10902255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Health of the Nation target on syringe sharing: a role for routine surveillance in assessing progress and targeting interventions.
    Durante AJ; Hart GJ; Brady AR; Madden PB; Noone A
    Addiction; 1995 Oct; 90(10):1389-96. PubMed ID: 8616467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug use and risk of bloodborne infections: a survey of female prisoners in British Columbia.
    Martin RE; Gold F; Murphy W; Remple V; Berkowitz J; Money D
    Can J Public Health; 2005; 96(2):97-101. PubMed ID: 15850026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gender differences in HIV risk behaviour of injecting drug users in Edinburgh.
    Davies AG; Dominy NJ; Peters AD; Richardson AM
    AIDS Care; 1996 Oct; 8(5):517-27. PubMed ID: 8893903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV infection in prisons. Most drug injectors stop injecting on entry to prison.
    Shewan D; Reid M; Macpherson A; Davies JB
    BMJ; 1995 May; 310(6989):1264. PubMed ID: 7767203
    [No Abstract]   [Full Text] [Related]  

  • 39. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
    Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
    Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV infection among injecting drug users in Asia: an evolving public health crisis.
    Wodak A; Crofts N; Fisher R
    AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.